Volume 2, Issue 1

Ann Blood Cancer. 2019;2(1):1008. | Research Article | Open Access
Abstract | Fulltext PDF

Superiority of CyBorD Over VAD is More Evident in First than in Second Line Treatment of Multiple Myeloma

Mosaad M El Gammal, Mohamed A Samra, Noha H Ibrahim and Maha A Abdel Fatah

Share This Article:


Subscribe to Our Newsletter